/PRNewswire/ Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices.
/PRNewswire/ Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices.
Zynex Announces Uplisting to the Nasdaq Global Select Market® prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Zynex to Present at the Ladenburg Thalmann Virtual Annual Healthcare Conference prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Zynex Announces 2021 First Quarter Earnings
News provided by
Share this article
2021 First Quarter
Orders increased 140%
Adjusted EBITDA loss $0.4 million
Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today reported financial results for its first quarter ended March 31, 2021.
First Quarter Financial Results Summary:
For the first quarter, the Company reported net revenue of $24.1 million, a 58% increase over the first quarter of 2020. Gross margins were 76% in the first quarter of 2021 and net loss was $0.7 million.
There was an Adjusted EBITDA loss of $0.4 million in the first quarter of 2021.